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We have identiﬁed 15 residues from the surface of sarcoplasmic reticulum Ca2+-pump ATPase, by
mass spectrometry using diethylpyrocarbonate modiﬁcation. The reactivity of 9 residues remained
high under all the conditions. The reactivity of Lys-515 at the nucleotide site was severely inhibited
by ATP, whereas that of Lys-158 in the A-domain decreased by one-half and increased by ﬁve-fold in
the presence of Ca2+ and MgF4, respectively. These are well explained by solvent accessibility, pKa
and nearby hydrophobicity of the reactive atom on the basis of the atomic structure. However,
the reactivity of 4 residues near the interface among A-, N- and P-domain suggested larger confor-
mational changes of these domains in membrane upon binding of Ca2+ (Lys-436), ATP (Lys-158) and
MgF4 (His-5, -190, Lys-436).
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Sarcoplasmic reticulum Ca2+-ATPase (SERCA1a) pumps two Ca2+
ions from the cytoplasm to its lumen by coupling the hydrolysis of
one ATP molecule [1]. According to the E1/E2 theory [2,3], the en-
zyme binds two Ca2+ ions and MgATP to form E1-2Ca2+ and E2-ATP
states, respectively, then to form phosphoenzyme E1P and E2P
states. The transition from E1P to E2P causes the afﬁnity reduction
of the Ca2+-binding sites and a change in the orientation from the
cytoplasmic side to the luminal side, followed by the release of
Ca2+ into the lumen. Finally, hydrolysis takes place and returns
the enzyme to its unphosphorylated form (E2 state).
The three-dimensional (3D) structures of this protein that cor-
respond to many of the intermediates have been determined by
electron microscopy of 2D crystals [4,5], by pioneered electron
crystallography [6,7] of 3D crystals and ultimately by X-ray crys-chemical Societies. Published by E
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ta).tallography [8–15]. The transmembrane domain, which exhibits
the Ca2+-binding sites, is composed of ten membrane-spanning
segments (M1–10). The N- and P-domains possess the nucleo-
tide-binding site and the phosphorylation site, respectively. The
A-, or actuator domain, plays a signiﬁcant role in converting the
conformational changes of the cytoplasmic domains and those of
the membrane domain through its rotation during the reaction cy-
cle. The coupling of the organization of the three cytoplasmic do-
mains with the conformation of this membrane domain induces
the key events in this reaction cycle [16,17].
A number of biochemical methods including chemical modiﬁca-
tion or crosslinking, limited proteolysis, and mutational analysis
were used for detecting substrate-induced changes in surface
accessibility or conformational changes and for testing structural
models of sarcoplasmic reticulum ATPase ([18–23], see Ref. [24]
for review). The reaction of diethylpyrocarbonate (DEPC) with a
protein has been reported as a good indicator for its surface acces-
sibility and the pKa of histidine and a few other amino acid residues
[25]. In this study, we have used DEPC to probe the conformational
changes of SERC1a. DEPC reacts somewhat speciﬁcally with
histidine residues at near-physiological pHs, but can also react
with lysine, cysteine, tyrosine residues (Fig. 1). The modiﬁed sites
could be analyzed by liquid chromatography mass spectrometry
(LC/MS) which has been used for peptide analysis of SERCA1a
[26–28]. Fifteen sites have been identiﬁed from the tryptic digest
of the DEPC-modiﬁed enzyme, and the effects of Ca2+, ATP, andlsevier B.V. All rights reserved.
Fig. 1. The reaction of histidine, lysine, and cysteine with diethylpyrocarbonate
(DEPC). Note that DEPC attacks both d-N and e-N atoms of histidine.
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have been addressed. Many of DEPC-modiﬁed residues were
consistent with the accessibility, pKa and the hydrophobicity esti-
mated from the crystal structures. However, the reactivity of some
residues in the vicinity of the interface among the A-, N- and P-do-
main suggested larger conformational changes of these domains
upon the binding of Ca2+ in membrane than in crystal form.
2. Materials and methods
2.1. DEPC modiﬁcation
The SR vesicles were prepared from rabbit skeletal muscle and
stored at 80 C, as described previously [29]. The modiﬁcation
reactions were performed for 20 or 40 min at 4 C with 2 mg/ml
SR vesicles in 5 mM MgCl2, 0.1 M KCl, 5% glycerol, 0.5 mM EGTA,
and 100 mM MOPS–NaOH (pH 7.0) or 100 mM MES–NaOH (pH
6.0). The reactions were initiated by adding 2 mM DEPC (Nacalai
Tesque, Kyoto) in acetonitrile (total amount of 1%). For the prepara-
tion of the E1-2Ca2+ state samples, 2.5 mM CaCl2 was added to a
mixture containing 100 mMMOPS–NaOH (pH 7.0). For the prepara-
tion of the E2-ATP state samples, 4 mM ATP was added to a mixture
containing 100 mMMOPS–NaOH (pH7.0). For the preparation of the
E2-MgF4 state samples, the SR vesicles were treated with MgF4 in
100 mMMES–NaOH (pH6.0) as described previously [30]. Themod-
iﬁcation reactionswere quenched by diluting eachmixture 30 times
with 0.5 M imidazole (pH 6.0). The DEPC-modiﬁed samples were
then centrifuged for 60 min at 4 C and 105000g, and the pellets
were dissolved in 5 mM MgCl2, 0.1 M KCl, 5% glycerol, and 50 mM
MOPS–Tris (pH 7.0). The samples were stored at 80 C.
2.2. LC/MS analysis
The 0.4 ml solutions, that were obtained after DEPC modiﬁca-
tion, containing 1 mg/ml SR vesicles, 5 mM MgCl2, 0.1 M KCl, 5%
glycerol, 0.1 mM CaCl2, and 50 mMMOPS–Tris (pH 7.0) were added
to 0.05 mg/ml trypsin and incubated at 37 C for 2 h. The solutions
were immediately dilutedwith 0.4 ml of 0.1% formic acid, cooled on
ice, and centrifuged for 20 min at 4 C and 346000g. The superna-
tants were ﬁltered using 2.1 mm ﬁlters, and 400 ll of each sample
was applied to LC/MS analysis. The samples were separated by re-
verse phase high-performance LC (RP-HPLC) using an ODS column
(20 cm  4.6 mm, 5 lm particle size, COSMOSIL) and a gradient of
H2O (solvent A) and 85% (v/v) acetonitrile (solvent B), each contain-
ing 0.1% formic acid at a ﬂow rate of 0.5 ml/min. The mobile phasecomposition was held at 0% solvent B for 5 min and then ramped
from 0% to 50% over 60 min and 50% to 100% over 20 min. The HPLC
was directly coupled to an electrospray ionization (ESI) ion trap
mass spectrometer (IT-MS, Finnegan) for acquisition of MSMS spec-
tra. The HPLC was also connected to an ESI Fourier transfer mass
spectrometer (FT-MS, Bruker) for acquisition of MS spectra with
highly accurate mass data.
2.3. Calculation of solvent accessibility and pKa
Solvent accessibility or SASA (in Å2) and pKa were calculated by
using GETAREA (http://curie.utmb.edu/getarea.html) with probe
radius of 1.4 Å and PROPKA (http://propka.ki.ku.dk/), respectively.
The crystal structures of SERCA1a in E1-2Ca2+, E2(TG + BHQ),
E2(TG)-AMPPCP, and E2(TG)-MgF4 states were examined using
the structures from the Protein Data Bank (PDB ID codes: 1SU4,
2AGV, 2DQS, and 1WPG, respectively). We also complementarily
examined E2(TG) (1IWAO), E2(TG analog)-AMPPCP (2BY4),
E2(TG)-AlF4 (2ZBG), and E2(CPA)-MgF4 (2OQJ), respectively.
2.4. Measurement of Ca2+-dependent ATPase activity and
phosphoenzyme (EP) formation
The Ca2+-dependent ATPase activity or EP formation were mea-
sured with 0.04 or 0.1 mg/ml SR vesicles, 5 mM MgCl2, 0.1 M KCl,
5% glycerol, 0.1 mM ATP or AT32P, 0.1 mM CaCl2, 50 mM MOPS–
Tris (pH 7.0), and 2 lM A23187 at 25 or 0 C, respectively, as de-
scribed previously [31,32].
3. Results and discussion
3.1. Identiﬁcation of the DEPC-modiﬁed amino acid residues
We have employed two LC/MS systems for more precise identi-
ﬁcation of the DEPC-modiﬁed amino acid residues. To acquire the
MS/MS data from the tryptic digests of the DEPC-modiﬁed enzyme,
we used liquid chromatography ion trap tandem mass spectrome-
try (LC–IT-MS/MS). The DEPC-modiﬁed or non-modiﬁed peptides
were identiﬁed from the MS/MS data by applying the database
search program, SEQUEST. However, there is a possibility that the
identiﬁed peptides might present false positive hits when the
MS/MS spectrum demonstrated poor peaks. To avoid these false
positive hits, the same samples were analyzed by liquid chroma-
tography–Fourier transfer mass spectrometry (LC–FT-MS), which
can obtain highly accurate mass. All of the identiﬁed peptides were
ﬁltered out and conﬁrmed whether their mass was identical with
the theoretical mass of the identiﬁed peptide (the mass er-
ror < 20 ppm), while considering that retention time. For example,
Fig. 2a shows a MS/MS spectrum, which was acquired by LC–IT-
MS/MS. The spectrum was identiﬁed as the peptide, 512–526
(MFVKGAPEPEGVIDR), and included the DEPC-modiﬁed Lys-515.
We then conﬁrmed whether there was a monoisotopic peak that
corresponded to the peptide with a theoretical mass of
1490.7672 Da, acquired by LC–FT-MS (Fig. 2b). The peak in
Fig. 2b represents a doubly-charged ion and a mass of
1490.7793 Da, with an error of 8.2 ppm. Similarly, 15 modiﬁed res-
idues (4 histidines, 10 lysines, and one cysteine) were identiﬁed
(Table 1) and located on the surface of the cytoplasmic domains.
It should be noted that some of the peptides from samples modi-
ﬁed with lower DEPC-reactivity at pH 6.0 were missing because
of the low S/N ratio of the peaks overlapped with other peptides.
3.2. DEPC-modiﬁed histidine residues
The peptide that included the DEPC-modiﬁed His-32 or His-190
was eluted in two distinct peaks, and the peptide that included the
Fig. 2. Identiﬁcation and quantiﬁcation of the DEPC-modiﬁed peptide, 515–525, by mass spectrometry. The MS/MS spectrum in (a) was acquired with LC–IT/MS and was
identiﬁed as the peptide, 510–525 that includes the DEPC-modiﬁed Lys-515. The upper spectrum reports the sequence of 510–525, and the asterisk denotes the DEPC-
modiﬁed site. The character b is the observed ion whose mass is identical with the N-terminal fragment mass, while the character y is the observed ion whose mass is
identical with the C-terminal fragment mass. The bold characters, y and b, denote the fragment that includes the DEPC-modiﬁcation sites. The MS spectrum in (b) was
acquired by FTMS; the measured peak is identical with the theoretical mass of the peptide. The chromatograms in (c), with a magniﬁed, selected mass range of 745.38–746.38
m/z, contains the identiﬁed peptide from the DEPC-treated enzyme in the absence (upper) or presence (lower) of ATP, respectively.
Table 1
Ratios of the DEPC-modiﬁed peptides (+substrate/substrate).
Peptide Residue E1-2Ca2+/E2(pH 7) E2-ATP/E2(pH 7) E2-MgF4/E2(pH 6) E2(pH 6)/E2(pH 7)
1–7 H5 1.03(0.8872)a 0.87(0.2251) 0.24(0.0006) 4.16
32–35 H32 0.96(0.8277) 1.11(0.3417) 0.66(0.3088) 1.83
32–35 H32 1.07(0.7494) 1.14(0.2200) 0.76(0.1844) 1.18
36–47 H38 0.93(0.6457) 1.08(0.4998) 1.41(0.0605) 0.98
36–47 H38 1.10(0.6652) 1.21(0.0057) 1.06(0.5026) 0.85
36–47 H38 1.13(0.5739) 1.33(0.0064) 1.06(0.3364) 1.31
36–47 H38 1.25(0.3645) 1.07(0.3037) 0.91(0.4003) 1.19
190–198 H190 1.35(0.1094) 1.24(0.0062) 0.43(0.0031) 0.47
190–198 H190 1.19(0.3089) 0.97(0.6989) 0.70(0.0152) 0.65
144–164 K158 0.42(6.12E-5) 0.50(0.0011) 5.24(4.14E-5) 0.05
165–174 K169 0.86(0.1975) 0.89(0.2840) 0.65(0.1003) 0.11
398–403 K400 0.92(0.6784) 0.89(0.1740) 0.90(0.8597) 0.11
432–451 K436 0.59(0.0091) 1.30(0.1289) 0.33(1.06E-5) 0.09
461–467 K464 1.05(0.6662) 0.92(0.0094) 0.98(0.1469) 0.09
512–524 K515 0.81(0.1748) 0.05(8.00E-10) 0.39(0.0006) 0.10
543–550 K544 0.81(0.2947) 1.03(0.7455) 0.90(0.7160) 0.10
543–556 K550 0.91(0.5258) 1.17(0.1924) Not Detectedb –c
545–556 K544,K550 0.92(0.5054) 0.90(0.1006) Not Detectedb –c
568–573 K572 0.93(0.5896) 0.93(0.3973) Not Detectedb –c
713–728 K713 0.93(0.8385) 0.91(0.6346) Not Detectedb –c
335–352 C344 0.74(0.2271) 0.82(0.0847) 0.11(1.86E-6) 3.92
a Numbers in parentheses represent p-values (t-test) of statistical signiﬁcance for the difference in peak area of the peptide between (+substrate) and (substrate).
b These peptides of both E2-MgF4 and E2 (pH 6) states were missing.
c These peptides of E2 (pH 7) were detected whereas those of E2 (pH 6) state were missing.
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observations were speciﬁc for histidine residues. The side chain
of the histidine residue possesses two nitrogen atoms, which can
react with DEPC to form two structural isomers. Moreover, the
binding of DEPC to the nitrogen atom of the imidazole ring forms
a cyclic, tertiary amine to form optical isomers.3.3. Identiﬁcation of the speciﬁc residues subjected to substrate-
sensitive DEPC modiﬁcation in SERCA1a
To identify the substrate-sensitive residues and the reactivity to
DEPC, tryptic digests of the enzymes, which were treated with
DEPC for 40 min in the presence or absence of substrate, were
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peak that corresponds to the peptide, 512–526, and includes the
DEPC-modiﬁed, Lys515, in the selected ion chromatograms (se-
lected mass range was 745.38–746.38m/z). We averaged 4–5 mea-
surements of the peak areas derived from the same peptides,
including the modiﬁed amino acid residues individually and then
calculated the ratios (substrate vs. +substrate): the averaged peak
areas of the +substrate sample were divided by the averaged peak
areas of the substrate sample (Table 1).
The ATPase and EP formation of modiﬁed enzyme were reduced
almost linearly with time and reached halfway ( 50% and 70%)
at 40 min without ATP, but maintained with ATP or MgF4, respec-
tively (data not shown), as reported previously [33,34]. This indi-
cated that the average fractions of enzyme having normal ATPase
activity and EP formation remained high (>75% and >85%) during
40-min period of DEPC modiﬁcation, respectively. As a result, the
ratios (substrate vs. +substrate) were almost the same (within
20%) when the period was decreased to 20 min from 40 min (data
not shown).
3.4. Speciﬁc residues, identiﬁed by substrate-insensitive DEPC-
modiﬁcation
Many of the DEPC-modiﬁed residues, which were identiﬁed by
mass spectrometry, did not show a signiﬁcant substrate-depen-
dent change on the reactivity of DEPC (namely, His-32, -38 and
Lys-169, -400, -464, -544, -550, -572, and -713; see Table 1). (Since
the residues Lys-544, 550, 572, and 713 had no data in the E2MgF4
state, we could not exclude the possibility that these residues show
a signiﬁcant MgF4-induced changes.) Such residues are always lo-
cated on the surface of the cytoplasmic domains in the crystal
structures corresponding to E2, E2ATP, E1-2Ca2+, and E2MgF4,
and most of them do not exhibit signiﬁcant differences in SASA
(solvent accessible surface area), as calculated from these crystal
structures (Table 2).
3.5. Lys-515, identiﬁed by the protection from DEPC modiﬁcation due
to the presence of ATP and MgF4
Lys-515 was the most reactive residue toward DEPC of all lysine
residues. However, the SASA of Lys-515 was estimated to be theTable 2
SASA values for DEPC modiﬁed sites in the crystal structures of sarcoplasmic
reticulum Ca2+-ATPase.
Site E2(TG + BHQ) E1-2Ca2+ E2(TG)-AMPPCP E2(TG)-MgF4
2AGV 1SU4 2DQS 1WPG
H5 0.89/0.00a 3.17/0.00 0.58/0.00 3.16/0.00
H32 0.00/10.21 0.00/9.82 0.00/7.22 0.00/13.12
H38 0.00/13.35 6.92/8.73 0.00/11.2 0.00/15.74b
8.35/5.42b
H190 2.58/0.00 0.00/6.71 4.07/0.00 0.00/8.96
K158 8.67 0.04 11.09 18.97
K169 32.09 18.82 25.26 24.18
K400 30.04 44.30 36.26 37.86
K436 37.58 28.90 38.14 25.24
K464 43.96 42.30 37.20 29.93
K515 0.00 0.01 1.45 0.21b 0.00b
K544 25.69 22.12 27.60 37.12b 4.65b
K550 29.43 40.84 27.10 44.17
K572 38.16 27.95 40.06 37.81
K713 12.32 36.16 26.45 7.33b 12.53b
C344 0.26 3.07c 1.43 0.00 1.17d 1.12b 3.81b
0.03e 0.29f
a Slash separated values indicate SASA of d-N and e-N atoms of histidine which
DEPC attacks.
b Distinct SASA values for multiple molecules in a unit cell.
c,d,e,f Distinct SASA values for E2(TG) (1IWAO), E2(TG analog)-AMPPCP (2BY4),
E2(TG)-AlF4 (2ZBG), and E2(CPA)-MgF4 (2OQJ), respectively.lowest of all the identiﬁed residues (0.0–1.45) (Tables 2), and its
pKa value remained >10 (data not shown). Lys-515 is also very
reactive to ﬂuorescein isothiocyanate (FITC) [35,36], which is a
hydrophobic and electrophilic agent, like DEPC, but more bulky.
Therefore, the high reactivity of Lys-515 toward DEPC may be
attributed to its hydrophobic, surrounding property rather than
tertiary-ﬁtted properties.
The ratio of the DEPC modiﬁcation, with and without substrate,
was 0.05 and 0.39 in the presence of ATP and MgF4, respectively.
Lys-515 is located in the ATP-binding site and occluded by AMPPCP
in the crystal structure of E2(TG)-AMPPCP that corresponds to E2-
ATP (Fig. 3). This is consistent with the almost-complete protection
from DEPC modiﬁcation by ATP. In the E2(TG)-MgF4 crystal struc-
ture, three cytoplasmic domains are closely gathered to form the
headpiece. The ATP-binding site, including Lys-515, then enters
the headpiece. This gathering probably protects Lys-515 from
DEPC-modiﬁcation by MgF4. Notably, the position of Lys-515 is al-
ready buried and shows a very low SASA (<0.01), even in the ab-
sence of AMPPCP or MgF4 (Table 2).
3.6. Lys-158, identiﬁed by the inﬂuences of Ca2+ and MgF4 that
decrease and increase the DEPC modiﬁcation respectively
The reactivity of Lys-158, which is located in the A-domain, to
DEPC decreased in the E1-2Ca2+ state and increased in the E2-
MgF4 state (Table 1). The A-domain changes its orientation sub-
stantially in the crystal structures (Fig. 3). Lys-158 orients toward
the front side of the structure in Fig. 3a and is buried on the inter-
face between the A- and P-domain in the E1-2Ca2+ crystal structure
while Lys-158 is exposed on the outside in the E2(TG + BHQ) crys-
tal structure (toward the rear of the structure in Fig. 3a). Accord-
ingly, the SASA of Lys-158 in the E1-2Ca2+ crystal structure (0.04)
is much lower than that of the E2(TG + BHQ) crystal structure
(8.6) (Table 2). It is likely that A-domain in the E1-2Ca2+ state is
similar but not completely the same as that of its crystal structure,
and dynamically ﬂuctuates between those of the crystal structures
of the E1-2Ca2+ and E2 states, since the reactivity ratio was de-
creased to only 0.4 by the presence of Ca2+ (Table 1). In the
E2(TG)-MgF4 crystal structure, Lys-158 changes its orientation to
protrude from the surface of the A-domain (toward the rear of
the structure in Fig. 3d), lending its amine group to be more ex-
posed and accessible to DEPC. The SASA of Lys-158 in the
E2(TG)-MgF4 crystal structure (20) is higher than that of the
E2(TG + BHQ) crystal structure (8.6) (Table 2). Since the ratio of
the DEPC-modiﬁed peptides (the area of the DEPC-treated sample
with the substrate/that of the DEPC-treated sample without the
substrates) reﬂects the substrate-induced changes, it is a good in-
dex for the detection of conformational changes in the cytoplasmic
domains of SERCA1a in solution.
3.7. Speciﬁc residues, identiﬁed by MgF4-induced protection from
DEPC modiﬁcation
In addition to the reactivity changes in Lys-158 and 515 as de-
scribed above, the reactivities of His-5, His-190, Lys-436, and Cys-
344 to DEPC decreased markedly in the E2MgF4 state, compared
with that in the apo enzyme E2 state. Therefore, the largest number
of amino acid residues changed their reactivity in E2MgF4 state
where the cytoplasmic domains undergo the largest conforma-
tional change in the crystal form [11]. In the E2(TG)MgF4 crystal
structure, His-190, found in the A-domain, is located in the vicinity
of the interface between the A- andN-domain and Lys-436, found in
the N-domain, is located in the vicinity of the interface among the
A-, N- and P–domain. His-5, found in the A-domain, and Cys-344,
found in the P-domain, are also located on the sites, which could
not be oriented toward the interface between these cytoplasmic
Fig. 3. Location of DEPC-modiﬁed amino acid residues in the crystal structures of sarcoplasmic reticulum Ca2+-ATPase (SERCA1a). The structures of SERCA1a in E2(TG + BHQ)
state (PDB ID code: 2AGV) and E2(TG)-AMPPCP state (PDB ID code: 2DQS), and E1-2Ca2+ state (PDB ID code: 1SU4), and E2(TG)-MgF4 state (PDB ID code: 1WPG) are shown in
(a), (b), (c), and (d), respectively. The DEPC-modiﬁed amino acid residues are depicted as the black, space-ﬁlling models.
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ingly, the SASAs of these residues do not show signiﬁcant differ-
ences between the crystal structures of E2(TG + BHQ) and
E2(TG)MgF4, although the SASA of Cys-344 decreases somewhat
in E2(CPA)MgF4 structure (0.29) as compared with that in E2(TG)
structure (3.07) (Table 2). Furthermore, ADP, which bind to the
ATP-binding site in the E2(TG)MgF4 crystal structure, has no effect
on SASAs of these residues, as compared with the E2(CPA)-MgF4
(2OQJ) crystal structure without ADP (data not shown). In solution
ormembrane the A- and N-domains of E2MgF4 state could ﬂuctuate
dynamically or rotate and interact strongly with each other and de-
crease the SASA of the residues. Otherwise, thapsigargine (TG),
which bind to the transmenbrane domain in the E2(TG)MgF4 crys-
tal structure, might interfere with the closer interaction between
the A-domain and the P-domain because it was not included in
the E2MgF4 state. TG might affect the cytoplasmic conformation
through the effect on the conformation of transmembrane domain.
In fact, the proteinase K-induced digestion of the loop of A-domain
to transmembrane helices was protected in the E2MgF4 state and
completely abolished by further addition of TG [18].
3.8. Lys-158, identiﬁed by ATP-induced protection from DEPC
modiﬁcation
The modiﬁcation of Lys-158 with DEPC was protected by ATP in
the absence of Ca2+ (in E2-ATP state) (0.5 in the reactivity ratio),
as well as by Ca2+ (in E1-2Ca2+ state) (0.4 in the ratio) (Table 1).
However, on the basis of the crystal structures, ATP merely affects
the conformation of the enzyme, without Ca2+ (E2 state), and
Lys-158 changes its orientation to protrude from the surface of
the A-domain (toward the rear of the structure in Fig. 3b), resultingits SASA to remain high (11.1) (Table 2). Contrastingly, Ca2+ directly
affects the ﬂuorescence of tryptophane in the transmembrane do-
main but ATP also affects it through the conformational change of
the cytoplasmic domains [22] where Lys-158 is located on the
interface between the A- and P-domain. Thus, the interface or
the orientation of A-domain of E2-ATP state in solution may
resemble more with that in the solution structure of E1-2Ca2+ than
that in the crystal structure of E2(TG)AMPPCP (Fig. 3). The loop of
A-domain to transmembrane helices was digested by proteinase K
in E2AMPPCP state at the same rate as E1-2Ca2+ state rather than
E2 state [20]. In E2(TG)AMPPCP crystal structure corresponding
to E2ATP state, TG might affect the conformational change of cyto-
plasmic domains through stabilizing the transmembrane domain,
resulting in cancelling the effect of ATP on the conformation of
the enzyme. In fact, TG reduces ATP binding afﬁnity by about
two orders of magnitude [13,37].
3.9. Lys-436, identiﬁed by the protection from DEPC modiﬁcation due
to the presence of either Ca2+ or MgF4
The modiﬁcation of Lys-436 with DEPC was protected by Ca2+,
as well as MgF4 (see above). However, the N-domain, where Lys-
436 is located, protrudes out and is further from the P- and A-do-
main in the E1-2Ca2+ crystal structure than in the other crystal
structures. Therefore, Lys-436 is exposed on the outside in the
E1-2Ca2+ crystal structure, and its SASA remains high (Table 2).
On the other hand, the distance between the N- and P-domains
in solution was measured by ﬂuorescence resonance energy trans-
fer (FRET) [38] and was found to increase only 3 Å upon Ca2+ bind-
ing. Glutaraldehyde cross-linking between Lys492 of N-domain
and Arg678 of P-domain in the presence of Ca2+ also suggested this
R. Narumi et al. / FEBS Letters 586 (2012) 3172–3178 3177possibility [39]. Furthermore, Fe2+-catalyzed oxidative cleavages
suggested that the N-domain can rotate in the E1-2Ca2+ state and
make contact with the phosphorylation site [28]. Since the DEPC-
modiﬁcation of Lys-158 in the A-domain was protected by Ca2+
as expected from E1-2Ca2+ crystal structure (see Section 3.6), it is
likely that the A-domain changes its orientation like that of E1-
2Ca2+ crystal structure whereas the N-domain does not protrude
out so much, but otherwise rotates and mimics that of E2MgF4
solution structure upon Ca2+ binding (in the E1-2Ca2+ state).
3.10. His-5 and Cys-344, identiﬁed by the acceleration of DEPC-
modiﬁcation at an acidic pH
The reactivity of His-5 and Cys-344 toward DEPC became higher
at a pH of 6, compared to a pH of 7, although acidic pH usually re-
duces the reactivity by the protonation of –NH2 or –S (Table 1).
These reactivity increases by the reduction of pH may be related
to the conformational change induced by the binding of protons.
In summary, 15 residues of SERCA1a have been identiﬁed by LC/
MS after the tryptic digest of a DEPC-modiﬁed enzyme. Eight resi-
dues were exposed outside and have high reactivity with DEPC un-
der all the conditions. The reactivity of Lys-515 at the nucleotide-
binding site was severely inhibited by ATP. These residues were
well explained by the solvent accessibility of the reactive atom in
the side chain and the presence of nearby charged or hydrophobic
residues of crystal structures, strongly suggesting that the ATPase
undergoes similar structural changes upon substrate binding in
crystal and in membrane. However, the reactivity of four residues
in the vicinity of the interface among the A-, N- and P-domain sug-
gested larger conformational changes of these domains in mem-
brane than in crystal form upon the binding of Ca2+ (Lys-436),
ATP (Lys-158) and MgF4 (His-5, His-190 and Lys-436).
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